Your browser doesn't support javascript.
loading
Site-Specific Dolasynthen Antibody-Drug Conjugates Exhibit Consistent Pharmacokinetic Profiles across a Wide Range of Drug-to-Antibody Ratios.
Clardy, Susan M; Uttard, Alex; Du, Bingfan; Catcott, Kalli C; Lancaster, Kelly L; Ditty, Elizabeth; Sadowsky, Jack; Zurita, Jeffrey; Malli, Naniye; Qin, LiuLiang; Bradley, Stephen P; Avocetien, Kenneth; Carter, Tyler; Kim, Dokyong; Nazzaro, Mark; Xu, Ling; Pillow, Thomas H; Zacharias, Neelie T; Lewis, Gail D; Rowntree, Rebecca K; Iyengar, Radha; Lee, David H; Damelin, Marc; Toader, Dorin; Lowinger, Timothy B.
Affiliation
  • Clardy SM; Mersana Therapeutics, Cambridge, Massachusetts.
  • Uttard A; Mersana Therapeutics, Cambridge, Massachusetts.
  • Du B; Mersana Therapeutics, Cambridge, Massachusetts.
  • Catcott KC; Mersana Therapeutics, Cambridge, Massachusetts.
  • Lancaster KL; Mersana Therapeutics, Cambridge, Massachusetts.
  • Ditty E; Mersana Therapeutics, Cambridge, Massachusetts.
  • Sadowsky J; Genentech, South San Francisco, California.
  • Zurita J; Mersana Therapeutics, Cambridge, Massachusetts.
  • Malli N; Mersana Therapeutics, Cambridge, Massachusetts.
  • Qin L; Mersana Therapeutics, Cambridge, Massachusetts.
  • Bradley SP; Mersana Therapeutics, Cambridge, Massachusetts.
  • Avocetien K; Mersana Therapeutics, Cambridge, Massachusetts.
  • Carter T; Mersana Therapeutics, Cambridge, Massachusetts.
  • Kim D; Mersana Therapeutics, Cambridge, Massachusetts.
  • Nazzaro M; Mersana Therapeutics, Cambridge, Massachusetts.
  • Xu L; Mersana Therapeutics, Cambridge, Massachusetts.
  • Pillow TH; Genentech, South San Francisco, California.
  • Zacharias NT; Genentech, South San Francisco, California.
  • Lewis GD; Genentech, South San Francisco, California.
  • Rowntree RK; Genentech, South San Francisco, California.
  • Iyengar R; Mersana Therapeutics, Cambridge, Massachusetts.
  • Lee DH; Mersana Therapeutics, Cambridge, Massachusetts.
  • Damelin M; Mersana Therapeutics, Cambridge, Massachusetts.
  • Toader D; Mersana Therapeutics, Cambridge, Massachusetts.
  • Lowinger TB; Mersana Therapeutics, Cambridge, Massachusetts.
Mol Cancer Ther ; 23(1): 84-91, 2024 Jan 03.
Article in En | MEDLINE | ID: mdl-37774393
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2024 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Immunoconjugates Type of study: Prognostic_studies Limits: Humans Language: En Journal: Mol Cancer Ther Journal subject: ANTINEOPLASICOS Year: 2024 Document type: Article Country of publication: